Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

601 articles

Research Review

Showing 1–1 of 1 articles · Keyword: Alzheimer’s disease Clear keyword

Discover nano2026ReviewNon-viral Gene DeliveryDrug Delivery

1. From molecular pathways to nanocarrier design: a translational framework for lipid-based nanoparticles in Alzheimer's disease

Manna P, Maity A, Roy S, Sahu S, Pradhan S, Ganguly Sc, Et Al.

Alzheimer's disease, being a complicated neurodegenerative disoder affects cognitive as well as memory functions. Characterised by amyloid-β aggregation, along with tau hyperphosphorylation, and cholinergic dysfunction, this disease is also associated with oxidative stress and neuroinflammation. Conventional clinical…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.